TDOC (Teladoc Health) COGS-to-Revenue : 0.31 (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Teladoc Health COGS-to-Revenue?

Teladoc Health's Cost of Goods Sold for the three months ended in Mar. 2025 was $197 Mil. Its Revenue for the three months ended in Mar. 2025 was $629 Mil.

Teladoc Health's COGS to Revenue for the three months ended in Mar. 2025 was 0.31.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Teladoc Health's Gross Margin % for the three months ended in Mar. 2025 was 68.73%.

Teladoc Health COGS-to-Revenue Historical Data

The historical data trend for Teladoc Health's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teladoc Health COGS-to-Revenue Chart

Teladoc Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.36

0.32

0.31

0.29

Teladoc Health Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															0.30	0.29	0.28	0.29	0.31

Teladoc Health COGS-to-Revenue Calculation

Teladoc Health's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	751.27	/	2569.574
	=	0.29

Teladoc Health's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	196.829	/	629.369
	=	0.31

Teladoc Health (NYSE:TDOC) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Teladoc Health's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	196.829 / 629.369
	=	68.73 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Teladoc Health COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Teladoc Health's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Teladoc Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Teladoc Health Inc (NYSE:TDOC) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

TDOC:Mexico 0LDR:UK 4LL:Germany T2DH34:Brazil

Address

2 Manhattanville Road, Suite 203, Purchase, NY, USA, 10577

Website

https://www.teladochealth.com

Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with Better convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.

Executives

Mala Murthy	officer: Chief Financial Officer	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Adam C Vandervoort	officer: Chief Legal Officer, Secretary	485 MADISON AVENUE, NEW YORK NY 10022
Thomas Mckinley	director
Andrew Turitz	officer: SVP - Business Development	C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Vidya Raman-tangella	officer: Chief Medical Officer	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Michael Willem Waters	officer: CHIEF OPERATING OFFICER	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Stephany Verstraete	officer: Chief Marketing Officer	C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Arnnon Geshuri	officer: Chief Human Resources Officer	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Daniel Trencher	officer: SVP Corporate Strategy	2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Mark Douglas Smith	director	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Laizer Kornwasser	officer: PRESIDENT, ENTERPRISE GROWTH	100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417
Karen L Daniel	director	2801 80TH STREET, KENOSHA WI 53141
Jason N Gorevic	director, officer: President & CEO
Richard J Napolitano	officer: Chief Accounting Officer	MSCI INC., 7 WORLD TRADE CENTER, 250 GREENWICH STREET, 49TH FLOOR, NEW YORK NY 10007
Jason Eric Evans	director	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027